Abstract. Vibrio, Aeromonas, Chromobacterium violaceum, and Shewanella (VACS) are water-associated Gramnegative organisms that can cause a variety of infections. The frequency, patient characteristics, and antimicrobial susceptibilities for 468 isolates from 442 patients from the Northern Territory were reviewed. Aeromonas spp. (312 of 468; 67%) were most commonly isolated followed by Vibrio spp. (71 of 468; 15%), Shewanella spp. (61 of 468; 13%), and C. violaceum (24 of 468; 5%). A strong male predominance was found (male to female ratio of 2.3:1). Skin and soft tissue isolations (373 of 468; 80%) from lower limb infections (222 of 371; 60%) were the most common clinical manifestation. The episodes were usually polymicrobial (281 of 468; 60%). Coisolates included Staphylococcus aureus (137 of 468; 29%), β-hemolytic streptococci (74 of 468; 16%), enterobacteriaceae (111 of 468; 24%), non-fermentative Gram-negative bacilli (35 of 468; 7%), and other VACS organisms (37 of 468; 8%). Antimicrobial resistance of VACS organisms to ciprofloxacin (0-4%), cefepime (0-3%), and gentamicin (0-0.8%) and Vibrio spp., Aeromonas spp., and Shewanella to cotrimoxazole (0-3%) was rarely shown. For water-associated lower limb skin and soft tissue infections in the tropics, clinicians should consider empirical antimicrobial therapy with agents active against S. aureus and VACS organisms.
INTRODUCTION
Vibrio spp., Aeromonas spp., Chromobacterium violaceum, and Shewanella spp. (VACS) are a group of oxidase-positive, Gramnegative organisms that occur naturally in aquatic environments.
Conditions that favor their survival include the warm ambient temperatures of the tropics, subtropics, and summers in more temperate regions. Aeromonas is the most ubiquitous, with a worldwide distribution, whereas C. violaceum reports have come exclusively from within 35 latitude of the Equator, including Florida and Louisiana in the United States.
Relative salinity also has a bearing on the prevalence of the organisms, with Vibrio spp., C. violaceum, and Shewanella spp. generally requiring estuarine or marine conditions, whereas Aeromonas spp. are also present in fresh water, including the drinking water of some countries. [1] [2] [3] [4] These organisms can cause a variety of illnesses, including severe skin and soft tissue infections, gastroenteritis, and bacteremia: V. vulnificus 5 and Shewanella spp. 1 are particularly associated with severe fulminant disease, especially in immunocompromised patients or those with underlying liver disease, and Aeromonas has been recognized as an important cause of infections in the aftermath of natural disasters, such as tsunamis. 6 C. violaceum is the rarest of these organisms, with published literature restricted to case reports or small case series. It is thought to usually confer severe disease with poor outcomes when isolated. 3 The best antimicrobial therapy has not been determined.
The Northern Territory comprises a land area of 1.2 million km 2 , the majority of which is north of the Tropic of Capricorn. The region has a sparse population of 230,000. There are two climate zones: tropical in the north with distinct wet (November to April) and dry seasons (May to October) and semiarid in the far south.
The aim of this study was to compare the relative frequencies, characteristics, and antimicrobial susceptibilities of the VACS organisms isolated from patients presenting to the Northern Territory public hospital system.
METHODS
Using the common database of the public laboratory system, unique isolations of any VACS organism in the laboratories of Royal Darwin, Katherine, Tennant Creek, Alice Springs, and Gove Hospitals in the Northern Territory of Australia between January 1 2000 and December 31, 2013 were identified. Isolations of these bacteria are not all notifiable to public health. Studies with other pathogens suggest that the public hospitals' laboratories detect the majority ( 90%) of microbiological pathogens in the Northern Territory. 7 Aeromonas spp. (67%; 9.9 of 100,000 population/year) were the most commonly isolated of the four organisms followed by Vibrio spp. (15%; 2.2 of 100,000 population/year), Shewanella spp. (13%; 1.9 of 100,000 population/year), and C. violaceum (5%; 0.76 of 100,000 population/year). Characteristics of the isolates and the patients are presented in Table 1 .
Patients with Vibrio spp., Shewanella spp., and C. violaceum more commonly resided in coastal regions, particularly East Arnhem Land and the Tiwi Islands (Figure 1 ). Isolation of these organisms occurred rarely in patients attending Alice Springs (1.3%) and Tennant Creek (0.6%) Hospitals, which are both in arid Central Australia, where year-round rainfall is low and salt water is absent. Aeromonas, however, was isolated at all hospital locations, including Alice Springs (8%) and Tennant Creek (2.2%).
The highest number of Aeromonas infections occurred in April, and a reduction in isolates was observed during the months of May to July. In contrast, year-round infection with less variability occurred with other VACS organisms ( Figure 2) .
The Vibrio spp. isolated were V. parahaemolyticus (25), V. alginolyticus (23), V. vulnificus (11), V. fluvialis (6), V. cholera (4), V. metschnikovii (1), and V. mimicus (1). Aeromonas spp. identified to species level were A. caviae (2), A. hydrophilia (103), A. salmonicida (3), and A. sobria (14) . Shewanella spp. identified to species level were S. algae (29) and S. putrifaciens (31).
VACS organisms were primarily isolated from skin and soft tissue (80%) specimens. Other sites included blood (5.2%), feces (5.4%), intra-abdominal (1.3%), respiratory (3.6%), eye (1.7%), and urine (1.9%). The site of skin and soft tissue isolates was most commonly the lower limb (222 of 373; 60%).
Infections in men were more likely with Vibrio and Shewanella (77% and 84%, respectively) than with Aeromonas (68%) and C. violaceum (46%). Bacteremia was more common with Vibrio (particularly V. vulnificus) and Shewanella species (9.9% and 9.8%, respectively) than other VACS organisms. Aeromonas skin and soft tissue infections (83%) were more common than gastrointestinal infections (5%; P 0.01).
C. violaceum epidemiology differed significantly with respect to sex, age, and site of isolation compared with the other In patients with coexistent VACS isolates, ages were assigned to C. violaceum initially and then Shewanella spp., Vibrio spp., and Aeromonas spp. isolates to avoid duplication counting of patient ages. Four patients had two discrete temporally separated episodes of VACS isolations during the time period of the study. Two patients had two episodes of a Shewanella sp. and an Aeromonas sp. isolation. One patient had two episodes: one Vibrio sp. and one Shewanella sp. One patient had two episodes of Aeromonas sp. detection.
*Data from 441 patients and 446 patient episodes. One patient with Vibrio spp. detected was of unknown age.
organisms: patients were more evenly matched for sex (male to female ratio of 0.85); infections occurred more commonly in children (25%); and isolates from feces (12.5%), respiratory samples (29%), and urine (12.5%) were more frequent. C. violaceum was also more commonly isolated from patients in the intensive care unit (ICU) (6; 25%) than Vibrio spp. Gram positives (56; 72%) were more commonly coisolated than aerobic Gram negatives (17; 25%) and other VACS organisms (13; 23%) for Vibrio spp. and Shewanella spp., whereas aerobic Gram negatives (39%) and Gram positives (42%) were both commonly isolated with Aeromonas spp.; other VACS organisms were uncommon (4%). The antimicrobial susceptibilities for the VACS organisms against a range of antibiotics are shown in Table 3 .
For Vibrio spp., Aeromonas spp., and Shewanella spp. isolates, resistance was rarely detected to the oral agents ciprofloxacin (0-4%) and cotrimoxazole (0-3%). Only small numbers of isolates were tested against the tetracyclines. Resistance to gentamicin was rare (0-0.8%) but occasionally found for tobramycin (0-5%). All isolates were susceptible to amikacin. In vitro resistance to ceftazidime (0-5%), piperacillin-tazobactam (0-11%), cefepime (0-3%), and meropenem (0-8%) was uncommon. Of a subgroup of Aeromonas isolates, 80 of 144 (56%) showed inducible ampC β-lactamases, and 5 of 93 (5%) showed inducible carbapenem resistance.
For C. violaceum, all isolates had inferred susceptibility to ciprofloxacin, gentamicin, and meropenem. Resistance to ceftazidime (62%), amikacin (17%), tobramycin (29%), and cotrimoxazole (14%) was found, though the numbers were small.
DISCUSSION
In this comparative study, we found Aeromonas spp. to be the most frequently isolated of the VACS organisms (67%). Vibrio spp. (15%), and Shewanella spp. (13%) were more commonly isolated than C. violaceum (5%), a rarely reported but important pathogen. The rates of Aeromonas (9.9 of 100,000 population/year) and Vibrio (2.2 of 100,000 population/year) found in this study are higher than those reported in France 8 (Aeromonas: 0.25 of 100,000 population/year) and the United States 5 (Vibrio: 0.42 of 100,000 population/year), although true rates are difficult to determine in the absence of EPIDEMIOLOGY OF VACS ORGANISMS mandatory laboratory reporting. The number of C. violaceum isolates that we report (24) is also the largest to date.
Consistent with their similar environmental and phenotypic characteristics, we found that individual VACS organisms share several epidemiological features. They occur with a striking predominance in adult males; skin and soft tissue sites are most likely to be involved, usually involving the lower limb, which is consistent with exposure during waterassociated activities. 9 Because this is the first study to compare the epidemiological characteristics of this group of organisms, the general applicability of our findings needs to be addressed. We believe, for the following reasons, that this study has generalizable validity. These features have previously been noted individually for all VACS organisms over wide geographical areas, 1,3,9-14 and in the closest study available for comparison, similar proportions of Aeromonas, Vibrio, and C. violaceum were found in skin and soft tissue infections in Thailand. 6 The male predominance, however, is not a feature of other skin infections, such as community-acquired, methicillinresistant S. aureus. 15 Possible reasons include a combination of factors, such as exposure-prone activities and contributing comorbidities, including alcoholism. 16 Estrogen also has been postulated to play a protective role against the effects of V. vulnificus endotoxin. 17 Infections are usually polymicrobial, particularly involving S. aureus, β-hemolytic streptococci, enterobacteriaceae, and other VACS organisms. Non-fermentative Gram negatives and anaerobes may also be present. This likely reflects wound inoculation with both the patient's own flora and those bacteria present in the aquatic environment. 6 Aeromonas spp. were the most commonly isolated organisms, consistent with its global distribution and ability to survive in all forms of environmental water at a wide range of temperatures. The salt water organisms Vibrio spp., C. violaceum, and Shewanella spp. were more common in coastal areas, where estuarine activities are more likely to bring individuals into contact with these organisms.
Aeromonas and Vibrio were more commonly associated with skin infections than gastroenteritis in our setting, which has been previously reported 8 in contrast to some other studies. 16 Factors that may explain this are the high standards of safe drinking water available to our population and water temperatures that favor year-round growth of these organisms in recreational areas. It also likely that differing laboratory isolation practices for Aeromonas impact on the reported prevalence of gastroenteritis in a particular region.
Aeromonas infections were less common during the dry season months of May to July, when inland fresh water is scarce, but seem to peak at the end of the wet season, when 
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Twenty-four isolates of C. violaceum came from 24 episodes of C. violaceum detection. One patient had a coexistent Vibrio sp. detected, and one patient had a coexistent Aeromonas sp. detection. Sixty-one isolates of Shewanella spp. came from 61 episodes of Shewanella spp. isolation. Six episodes had a coexistent Vibrio spp. detected, five episodes had a coexistent Aeromonas spp. detected, and one episode had both an Aeromonas sp. and Vibrio sp. Seventy-one isolates of Vibrio spp. came from 61 episodes where Vibrio spp. were detected. Six episodes were with coexistent Shewanella spp., four episodes included coexistent Aeromonas sp., two episodes had a coexistent different Vibrio sp. detected, and one episode had both an additional Vibrio sp. and an Aeromonas sp. isolated. One episode coexisted with C. violaceum. Three hundred twelve Aeromonas spp. isolates arose from 300 episodes of Aeromonas spp. detection. In four episodes, Vibrio sp. was coexistent. In five episodes, Shewanella sp. was coexistent. In one episode, C. violaceum was coexistent. Two episodes included isolation of two distinct Aeromonas spp. Two additional episodes included multiple mixed VACS organisms.
maximal groundwater is present. Other VACS infections occurred year-round in our setting in contrast to the pattern seen with Vibrio outside the tropics. 9 We have not directly looked at clinical outcomes for these organisms, which is a limitation of this study. However, comparing rates of bacteremia gives an indication of whether illness severity differs between VACS organisms. Vibrio spp., particularly V. vulnificus, and Shewanella spp. are well-recognized to cause fulminant skin and soft tissue infections with bacteremia, and we found them be more commonly associated with bacteremia than either Aeromonas spp. or C. violaceum.
We have found that C. violaceum, while sharing some characteristics of the VACS organisms, also exhibits differences in its epidemiology. Infections occur equally in both sexes, children are more commonly affected compared with those infected with other VACS organisms, and the organism is frequently isolated from urine, the respiratory tract, and feces as well as skin and soft tissue. Previous case series 3, 18 have shown a male predominance for this organism, but infections in immunocompromised and healthy females have also been reported. 14, 19 Children, often with underlying immunodeficiencies such as chronic granulomatous disease, 3, 20 are known to be at risk of developing disease.
Additionally, although not as likely to be associated with bacteremia as Vibrio spp. and Shewanella spp., we found that isolation of C. violaceum occurs more commonly in the ICU population compared with other organisms. This may be an indicator of severity of disease, but in the absence of clinical data, it could also suggest that compromised patients are more likely to be colonized with this organism.
This study shows in a tropical setting that C. violaceum is not commonly isolated and can occur in unexpected sites. Infection should be considered in patients with infections not responding to standard antimicrobial therapy in the setting of water exposure. Our antimicrobial susceptibility data are limited by small numbers but support the empirical use of meropenem, ciprofloxacin, and gentamicin for C. violaceum infections. These antibiotics have been used elsewhere in successful treatment regimens. 12, 13 Earlier in vitro studies have showed ciprofloxacin to be the most potent of these, 21 and this should, therefore, be incorporated in first-line regimens targeting this organism.
Regarding our inferred antimicrobial susceptibility data for Shewanella spp. and C. violaceum from P. aeruginosa results, we believe that this is reasonable for the following reasons.
(1) Relatively low numbers of Shewanella spp. and C. violaceum make it unlikely that independent standards will be developed. (2) P. aeruginosa is also an oxidase-positive environmental organism with some similar features to Shewanella spp. and C. violaceum. It is reasonable to argue that Vibrio spp. susceptibility criteria could be used as an alternative. Examining our data, the susceptibility results for the antimicrobials reported were similar using both Vibrio spp. and Pseudomonas spp. inferred susceptibility results. Moving forward, we believe that, when these organisms are isolated, they should have minimum inhibitory concentration (MIC) testing performed against clinically relevant antibiotics, which is currently the case for other tropical organisms, such as Burkholderia pseudomallei.
Our antimicrobial susceptibility data for Vibrio, Aeromonas, and Shewanella support the empirical use of aminoglycosides, cotrimoxazole, ciprofloxacin, and cefepime in fresh and salt water-associated skin and soft tissue infections in our region. Although we do not have clinical outcome data to support this, similar susceptibilities and successful outcomes have been noted elsewhere with these antibiotics. 1, 16, 22 Local antimicrobial susceptibility data are important, because cotrimoxazole resistance in Spain and Taiwan restricts its empirical use in Aeromonas infections. 23, 24 Additional empirical cover should target likely copathogens, particularly S. aureus. Anaerobes, non-fermentative Gram-negatives, and enterococci should be covered in life-threatening infections.
Caution is advised against reliance on third generation cephalosporins for the treatment of Aeromonas infections, because more than one-half of a subset of isolates showed inducible resistance, despite in vitro susceptibility. This is caused by inducible ampC cephalosporinases 25 and has been shown to occur during treatment of Aeromonas bacteremia. 26 Cefepime offers a potential alternative agent, because it is not affected by this enzyme. In contrast, all Vibrio isolates were susceptible to ceftriaxone, and in vitro studies have suggested a role for a combination of a β-lactam with ciprofloxacin for treatment of V. vulnificus sepsis. 27 Meropenem was not universally active against Vibrio and Aeromonas isolates, and inducible carbapenem resistance was additionally detected in a subset of in vitro susceptible Aeromonas isolates. Inconsistencies are also known to occur between antimicrobial susceptibility testing methods, such as disk diffusion and broth microdilution with carbapenems, for this organism. 28 It is notable that the most common carbapenemase present in Aeromonas (CphA) has a very narrow substrate profile that would not affect cefepime, although VIM metallobetalactamases (MBLs) do also occur. 25 Treatment failure caused by the development of carbapenem resistance in Shewanella bacteremia has also been reported 29 ; therefore, carbapenem monotherapy in severe water-associated infections cannot be recommended.
In summary, VACS are a group of water-associated environmental organisms associated with skin and soft tissue infections in the tropics. They should be considered in lower limb infections after fresh or salt water exposure. Polymicrobial infections usually occur. Empirical antibiotic treatment with agents, such as ciprofloxacin, cotrimoxazole, and aminoglycosides, with appropriate S. aureus cover should be considered, and identification of organisms and antimicrobial susceptibility testing should be performed.
